Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | PRKCA | P17252 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20668476 | 0.89 | NPSR1 (0.38) | NPSR1RXFP1ALDH1A1LMNAL3MBTL1 | |
| SCHEMBL22266825 | 0.88 | NPSR1 (0.35) | NPSR1ALDH1A1L3MBTL1MEN1KMT2A | |
| SCHEMBL20668205 | 0.86 | NPSR1 (0.42) | NPSR1RXFP1ALDH1A1LMNAL3MBTL1 | |
| SCHEMBL20668206 | 0.86 | NPSR1 (0.46) | NPSR1RXFP1ALDH1A1LMNAL3MBTL1 | |
| SCHEMBL22266836 | 0.85 | ALDH1A1 (0.35) | NPSR1RXFP1ALDH1A1LMNATP53 | |
| SCHEMBL20668203 | 0.84 | NPSR1 (0.40) | NPSR1RXFP1ALDH1A1L3MBTL1MEN1 | |
| SCHEMBL24952540 | 0.84 | NPSR1 (0.37) | NPSR1ALDH1A1LMNA | |
| SCHEMBL20668454 | 0.84 | NPSR1 (0.42) | NPSR1RXFP1ALDH1A1LMNAL3MBTL1 | |
| SCHEMBL22266849 | 0.83 | NPSR1 (0.40) | NPSR1RXFP1ALDH1A1 | |
| SCHEMBL26238604 | 0.83 | NPSR1 (0.40) | NPSR1RXFP1ALDH1A1LMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10774029-B2 | Compound, resin, resist composition and method for producing resist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-09-15 | — | — | US | disclosed |
| US-20190025698-A1 | COMPOUND, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190025698-A1 | COMPOUND, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | C1R, C9, RER1 | NPSR1 1740/4885RXFP1 452/4885ALDH1A1 747/4885 |
| US-10774029-B2 | Compound, resin, resist composition and method for producing resist pattern | C1R, C9, RER1 | NPSR1 1722/4885RXFP1 447/4885ALDH1A1 776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.